Calithera Biosciences, Inc. (CALA) DCF Valuation

Calithera Biosciences, Inc. (CALA) DCF Valuation
  • Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • Predeterminadas Para Un Uso Rápido Y Eficiente
  • No Se Necesita Experiencia; Fáciles De Seguir

Calithera Biosciences, Inc. (CALA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you're an investor or analyst, this (CALA) DCF Calculator is your go-to resource for accurate valuation. Loaded with real data from Calithera Biosciences, Inc., you can adjust forecasts and observe the effects in real-time.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2018
AY2
2019
AY3
2020
AY4
2021
AY5
2022
FY1
2023
FY2
2024
FY3
2025
FY4
2026
FY5
2027
Revenue 22.3 .0 .0 9.8 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -100 0 0 -100 -50 -50 -50 -50 -50
EBITDA -57.3 -88.0 -88.3 -115.4 -38.3 .0 .0 .0 .0 .0
EBITDA, % -257.4 100 100 -1183.93 100 20 20 20 20 20
Depreciation .5 1.8 1.9 1.4 1.4 .0 .0 .0 .0 .0
Depreciation, % 2.27 100 100 14.71 100 63.4 63.4 63.4 63.4 63.4
EBIT -57.8 -89.9 -90.1 -116.9 -39.7 .0 .0 .0 .0 .0
EBIT, % -259.67 100 100 -1198.64 100 20 20 20 20 20
Total Cash 136.2 157.4 115.2 59.5 25.5 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 2.0 .5 1.5 .0 .0
Account Receivables, % 8.97 100 100 0 100
Inventories -2.0 -.5 -1.5 .0 .0 .0 .0 .0 .0 .0
Inventories, % -8.97 100 100 0 100 58.21 58.21 58.21 58.21 58.21
Accounts Payable 1.2 2.1 2.0 3.7 .7 .0 .0 .0 .0 .0
Accounts Payable, % 5.6 100 100 37.44 100 68.61 68.61 68.61 68.61 68.61
Capital Expenditure -.2 .0 -.1 -.1 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % -0.96162 100 100 -1.51 100 -0.49386 -0.49386 -0.49386 -0.49386 -0.49386
Tax Rate, % 52.42 52.42 52.42 52.42 52.42 52.42 52.42 52.42 52.42 52.42
EBITAT -54.4 -86.3 -88.5 -167.9 -18.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -52.9 -83.7 -86.8 -165.0 -20.5 -.7 .0 .0 .0 .0
WACC, % 4.19 4.28 4.37 4.45 2.12 3.88 3.88 3.88 3.88 3.88
PV UFCF
SUM PV UFCF -.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -24
Equity Value 23
Diluted Shares Outstanding, MM 5
Equity Value Per Share 4.62

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real CALA financials.
  • Real-World Data: Historical data and forward-looking estimates (as highlighted in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe how your inputs affect Calithera’s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Comprehensive CALA Data: Pre-loaded with Calithera Biosciences' historical performance metrics and future projections.
  • Customizable Assumptions: Tailor growth rates, profit margins, discount rates, tax assumptions, and capital investments.
  • Interactive Valuation Tool: Automatic recalculation of Net Present Value (NPV) and intrinsic value based on user-defined parameters.
  • What-If Analysis: Develop various forecasting scenarios to evaluate different potential valuation results.
  • Intuitive User Interface: Designed for ease of use, making it accessible for both industry experts and newcomers.

How It Works

  1. Step 1: Download the Excel file for Calithera Biosciences, Inc. (CALA).
  2. Step 2: Review Calithera's pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
  5. Step 5: Analyze the results and utilize them for your investment decisions.

Why Choose This Calculator for Calithera Biosciences, Inc. (CALA)?

  • Accuracy: Utilizes real Calithera financial data to ensure precise calculations.
  • Flexibility: Allows users to easily test and adjust inputs as needed.
  • Time-Saving: Avoid the complexities of constructing a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
  • User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.

Who Should Use This Product?

  • Investors: Evaluate Calithera Biosciences’ valuation before making stock transactions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess future projections.
  • Startup Founders: Understand the valuation processes of established biotech firms like Calithera.
  • Consultants: Provide detailed valuation analyses and reports for clients in the biotech sector.
  • Students and Educators: Utilize current market data to study and teach valuation principles.

What the Template Contains

  • Pre-Filled DCF Model: Calithera Biosciences’ financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Calithera Biosciences’ profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.